FridaySep 28, 2018 11:52 am

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Achieves Successful Introduction of New Hemp-Infused Product Line into Target Market

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium functional food and beverage business, recently launched its “Oki” product line of drinks and supplements featuring hemp extracts into the mainstream market. An article discussing the company reads, “Phivida conducted extensive consumer research before the Oki product launch, during which it was able to align the product line with the ethos, habits and attitudes of its target market. The research revealed that consumers of active hemp extracts prioritize healthy lifestyles and seek out functional beverages. They are more likely to reject drinks that contain large amounts of sugar and processed ingredients, and…

Continue Reading

WednesdaySep 26, 2018 2:24 pm

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Moving Closer to Full Vertical Integration in U.S. Cannabis Space

Sunniva’s (CSE: SNN) (OTCQX: SNNVF) is moving closer to its key strategy in becoming a fully integrated cannabis company. CEO Dr. Anthony Holler reviews the company’s developments over the past six months in a recent article, which indicates, “We made great progress in Q2 2018 towards our goal of becoming a vertically integrated cannabis company in the U.S. In California, construction progressed at our phase one 325,000 square foot state-of-the-art Sunniva California Campus with completion targeted by the end of this year and first harvest expected in Q1 2019. Our extraction facility began generating revenue this quarter. We continue to…

Continue Reading

TuesdaySep 25, 2018 2:58 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Solves Unique Challenges Faced by the Cannabis Industry

BLOCKStrain Technology (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, offers the cannabis market a single-source accountability system. A recent article discussing the company’s innovative platform reads: “While supply chain transparency and verification are ongoing issues for various industries, in an emerging industry like the cannabis market, in which regulations are still being established and the proverbial kinks are still being worked out, the need for a reliable means of seed-to-sale tracking is even more acute. … Until recently, cannabis products were largely available only on the black market. As cannabis availability and legalization now continue to expand…

Continue Reading

FridaySep 21, 2018 2:14 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH™, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH™ was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://cnw.fm/0l9eM). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,…

Continue Reading

FridaySep 21, 2018 2:07 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategically Employs R&D Strategy to Achieve Increased Productivity

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to give its investors more bang for their buck when it comes to research and development (“R&D”), as it has been proven that smaller companies achieve higher R&D productivity. A recent article discussing the company reads: “PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has taken this advice to heart. The health sciences company has three distinct research programs underway. Top of the line is a non-opioid pain treatment based on cannabinoids to be administered through a proprietary nose-to-brain, soluble gel (Sol-gel) drug delivery system. The research…

Continue Reading

WednesdaySep 19, 2018 12:35 pm

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Has Achieved DTC, CNS Eligibility to Simplify Settlement, Boost Liquidity

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium functional food and beverage business based in Vancouver, British Columbia, was recently awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the U.S. OTCQX® Best Market. A recent article discussing this reads, “Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.” To…

Continue Reading

FridaySep 14, 2018 2:34 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Revolutionizes Visibility, IP Protection in the Cannabis Supply Chain

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, enables cannabis growers to defend their intellectual property rights with an authentic, verifiable chain of evidence embedded in the blockchain from genome to sale. A recent article discussing the company reads: “That’s where BLOCKStrain’s platform comes in by providing a gene-registration defense of intellectual property rights and establishing historical proof of ownership. That’s huge for cannabis growers seeking to develop their own brands for an increasingly astute and knowledgeable base of loyal consumers. The authenticity of a particular cannabis strain is followed from genome to sale, providing…

Continue Reading

FridaySep 14, 2018 11:32 am

CannabisNewsBreaks – Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Unveils New Beverage Line

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, elevate health, and enhance productivity. The company recently launched the first two flavors in its new line of beverages. A recent article discussing the beverages reads: “Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages include the new superfood lion’s mane mushroom, which is part of Koios’ reformulated and improved range of cognitive-enhancing drinks. Other flavors soon to come in the same line are blood orange and apricot vanilla.”…

Continue Reading

FridaySep 14, 2018 11:26 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Nature Identical Peptides Testing

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is steadfast in its mission of developing preventive therapies for health-conscious consumers who want nature-based products. A recent article discussing the company reads, “In recent months, the company has advanced the testing of its Nature Identical™ peptides toward the treatment and prevention of cancers such as the glioblastoma, the disease that took the life of Sen. John McCain. The company’s research team identified eight peptide candidates for the anticipated line of wellness products earlier this year, building on analysis of the Caribbean blue scorpion whose venom is widely reputed…

Continue Reading

FridaySep 14, 2018 11:20 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Leverages Need for Speed in Fast-Track Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is leveraging the need for speed in the likes of Formula One racing with its innovative drug delivery platform. A recent article discussing the company’s DehydraTECH™ reads, “In recent in vivo tests, the technology delivered 203 nanograms per milliliter (ng/mL) of nicotine in 15 minutes, 70 percent more than the control. Such rapidity may rival smoking; particularly as new research (http://cnw.fm/gi1Aw) suggests that ‘nicotine takes much longer than previously thought to reach peak levels in the brains of cigarette smokers.’ For tobacco industry giants on the search for safer delivery methods than smoking, the DehydraTECH™…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000